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J. K. Potts*, S. E. Echternkamp†, T. P. L. Smith† and J. M. Reecy*
*Department of Animal Science, Iowa State University, Ames, IA 50011, USA. †USDA, ARS, US Meat Animal Research Center, Clay Center,
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Summary Myostatin, a member of the transforming growth factor-b superfamily, is a negative
regulator of skeletal muscle growth. Cattle with mutations that inactivate myostatin exhibit
a remarkable increase in mass of skeletal muscle called double muscling that is accom-
panied by an equally remarkable decrease in carcass fat. Although a mouse knockout model
has been created which results in mice with a 200% increase in skeletal muscle mass,
molecular mechanisms whereby myostatin regulates skeletal muscle and fat mass are not
fully understood. Using suppressive subtractive hybridization, genes that were differentially
expressed in double-muscled vs. normal-muscled cattle embryos were identified. Genetic
variation at other loci was minimized by using embryonic samples collected from related
Piedmontese · Angus dams or Belgian Blue · Hereford dams bred to a single sire of the
same breed composition. Embryos were collected at 31–33 days of gestation, which is
2–4 days after high-level expression of myostatin in the developing bovine embryo. The
suppressive subtraction resulted in 30 clones that were potentially differentially expressed,
19 of which were confirmed by macroarray analysis. Several of these genes have biological
functions that suggest that they are directly involved in myostatin’s regulation of skeletal
muscle development. Furthermore, several of these genes map to quantitative trait loci
known to interact with variation in the myostatin gene.
Keywords bovine, gene expression, macroarray, myostatin.
Introduction
Culley (1807) first described the double-muscled phenotype
in cattle. Increased skeletal muscle mass in double-muscled
cattle, which occurs prenatally, is primarily because of
hyperplasia (an increase in muscle fibre number) coupled
with a small amount of hypertrophy (increased myofibre
diameter) (Swatland & Kieffer 1974). Belgian Blue and
Piedmontese double-muscled cattle have an 15–30%
increase in skeletal muscle mass, in addition to increased
birth weight, rib eye area, feed efficiency, and improved
retail product yield (Hanset 1986). However, double-mus-
cled cattle have problems with dystocia, decreased female
fertility, and lower stress tolerance (Hanset 1991). Because
of these management problems, there has been limited use
of double-muscled cattle in commercial beef production in
the United States. Furthermore, the extremely low level of
intramuscular fat deposition typically results in down gra-
ding of the meat in the current marbling-based grading
systems, which relegates meat from double-muscled cattle
to niche markets.
In 1997, myostatin was identified by virtue of homology
to conserved regions within transforming growth factor-b
(TGFB) superfamily genes (McPherron et al. 1997). To
determine the biological function of this new TGFB super-
family member, knock-out mice were produced. Myostatin
null mice have a dramatic 200% increase in skeletal
muscle mass, which is due to myofibre hyperplasia
(McPherron et al. 1997). Myostatin must be proteolytically
processed to be active, and nine cysteine residues are
necessary for proper folding and homodimerization (Berry
et al. 2002), but the molecular mechanisms whereby
myostatin regulates skeletal muscle growth remains to be
elucidated.
Myostatin mRNA is first detected at very low levels in
16 days bovine embryos, but at much higher levels at
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29 days of gestation (Kambadur et al. 1997). Myostatin
expression in early embryos is primarily restricted to the
myotomal compartment of the somite, which will give rise
to myoblasts (Gagniere et al. 1999). Later in embryonic
development, myostatin is expressed in all skeletal muscles
and its expression is seen throughout development (Lee &
McPherron 1999).
Myostatin has been reported to decrease myoblast pro-
liferation (Thomas et al. 2000; Rios et al. 2001; Taylor et al.
2001). Myoblasts treated with myostatin appear to exit the
cell cycle and enter into a quiescent state. In addition,
myostatin inhibits terminal differentiation of myoblasts
(Artaza et al. 2002; Rios et al. 2002). Furthermore,
myostatin represses MYOD1 mRNA expression, which is
important for myogenic commitment (Oldham et al. 2001).
In total, myostatin appears to have several downstream
targets, whose role may be to regulate skeletal myoblast cell
cycle progression and terminal differentiation.
In this study, suppressive subtractive hybridization (SSH)
was used to identify genes that are differentially expressed in
double-muscled vs. normal-muscled embryos. These genes
may be downstream targets of myostatin and/or interact
with myostatin genetic variants.
Materials and methods
Embryo collection
Two sets of dams were used to produce embryos. The first
set included 21 Piedmontese · Angus cross cows that were
heterozygous for the A to G transition mutation in myost-
atin that causes double muscling in the Piedmontese breed
(Kambadur et al. 1997). Calves were early weaned from the
dams shortly before dams were synchronized with two
Prostaglandin F (PGF) injections 12 days apart. They were
superovulated using FSH injections for four consecutive
days, and artificially inseminated using semen from a single
Piedmontese · Angus bull previously determined to be
heterozygous for the myostatin mutation. Pregnant dams
(n ¼ 16) were slaughtered 2–4 days after the initial expres-
sion of myostatin in the developing embryo (Kambadur
et al. 1997), on day 30, 31, or 32 post-insemination. The
reproductive tract was promptly removed after death and
embryos (n ¼ 52) dissected from the tract and snap frozen
in liquid nitrogen. Myostatin genotypes of the embryos were
determined by amplification and sequencing of RT-PCR
products as described (Kambadur et al. 1997).
The second set of dams included 29 Belgian
Blue · Hereford females heterozygous for the 11 bp deletion
causing myostatin inactivation in the Belgian Blue breed.
Dams (n ¼ 29) were synchronized and inseminated similar
to the first set with semen from a single Belgian Blue ·
MARC III bull that was heterozygous for the myostatin
inactivating mutation, but these dams were not superovu-
lated. Pregnant dams (n ¼ 21) were slaughtered on day 31
(n ¼ 7), 32 (n ¼ 10), or 33 (n ¼ 6) post-insemination, and
embryos (n ¼ 23) collected as above. Embryos were geno-
typed for the 11 bp deletion as described (Kambadur et al.
1997).
RNA processing
Ribonucleic acid was extracted using the RNeasy midi kit
(Qiagen, Valencia, CA, USA) according to the manufac-
turer’s protocol. Briefly, tissue (150 mg) from two normal-
(32 days old) and two double-muscled embryos (31 and
32 days old) was homogenized in the presence of RLT buffer
(Qiagen) with a Polytron (Brinkman Instruments,
Westbury, NY, USA) for 45 s at 15 000 rpm. Protein was
degraded by digestion with proteinase K (20 mg/ml; Sigma,
St Louis, MO, USA) at 55 C for 20 min. The RNA sample
was bound to an RNeasy midi column (Qiagen) and ge-
nomic DNA was degraded by in-column DNase1 (20 ll)
digestion at room temperature for 15 min. The RNA on the
column was subsequently eluted in RNase-free water
(50 ll). PolyA mRNA was purified from total RNA with an
Oligotex Mini Spin Column (Qiagen).
Suppressive subtractive hybridization
Forward and reverse SSH (PCR-select cDNA subtraction;
ClonTech, Palo Alto, CA, USA) was completed according to
the manufacturer’s protocol with 1 lg mRNA as starting
material. Double-stranded cDNA was digested with RsaI,
and adaptors were ligated to the cDNA ends. Hetero-hybrids
of the tester and driver were generated by an initial
hybridization of tester and driver cDNA at 68 C. In order to
further enrich for differentially expressed sequences, a sec-
ond hybridization was also completed. Differentially
expressed cDNA was PCR amplified with PCR reaction
buffer (1·), dNTPs (10 mM), PCR primer 1 (10 mM), and
Advantage cDNA polymerase mix (50·). The PCR condi-
tions consisted of 94 C for 5 min followed by 28 cycles of
94 C for 30 s, 66 C for 30 s, and 72 C for 1.5 min. A
secondary PCR amplification was completed with PCR
reaction buffer (1·), nested PCR primer 1 (10 lM), nested
PCR primer 2R (10 lM), dNTPs (10 mM), and Advantage
cDNA polymerase mix (50·). Secondary PCR conditions
included 12 or 15 cycles of 94 C for 30 s, 68 C for 30 s,
and 72 C for 1.5 min.
DNA isolation
The final PCR products were subcloned into pT-Advantage
(ClonTech) according to the manufacturer’s protocol.
Clones were plated on LB agar in the presence of ampicillin
(50 mg/ml). Plasmid DNA was isolated by alkaline lysis
(protocol partially adapted from Marra et al. 1997). Inserts
size was estimated by excision with EcoRI restriction endo-
nuclease digestion and size separated on a 1% agarose gel.
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Sequencing and analysis
A total of 58 plasmids (31 from the forward subtraction and
27 from the reverse subtraction) were sequenced with an
ABI 3700 sequence analyzer (Applied Biosystems Inc.,
Foster City, CA, USA). Clone identification was predicted by
BLAST analysis against GenBank NR database. Comple-
mentary DNA clones were randomly assigned numbers and
putative gene names were given to clones with >80%
homology to a known gene.
cDNA macroarray
In order to maximize the identification of genes isolated by
SSH, a macroarray was generated by spotting PCR amplified
cDNA onto a nylon membrane. The PCR programme
included 2 min at 95 C, 30 cycles of 95 C for 30 s, 52 C
for 30 s, and 72 C for 2 min, followed with a final exten-
sion at 72 C for 5 min.
Amplified cDNA clones were manually spotted in dupli-
cate onto membranes (BioRad, Hercules, CA, USA) using
hand-held multiprint equipment (V & P Scientific, San
Diego, CA, USA). The cDNA on the blot was denatured with
0.5 N NaOH/3 M NaCl solution for 5 min, neutralized with
6· SSC solution for 5 min, and cross-linked (120 000 lJ) to
the blot with a UV Stratalinker 2400 (Stratagene, La Jolla,
CA, USA).
Radiolabelled target was generated using a mixture of
PCR amplified cDNA from the 58 clones that had been
sequenced (50 ng/ll) in order to insure that all unique
clones had been identified or from cDNA generated from
homozygous wild-type and homozygous double-muscled
embryos. The target mixture included 10· reaction buffer
(1·), random primers (50 lM) (Ambion, Austin, TX, USA),
a32P dCTP (15 lCi), and exo-Klenow enzyme (0.5 unit).
Radiolabelled probes were purified with Bio-spin columns
(BioRad). Standard methods for hybridization were used.
Macroarray blots were exposed to a phosphoimaging screen
for 1 h and scanned on a phosphoimager (Molecular
Dynamics, Piscataway, NJ, USA). ImageQuant (Amersham,
Piscataway, NJ, USA) was used to determine signal
intensity.
COMPASS and BLAST analysis of differentially
expressed clones
Putative chromosomal location of the identified clones was
predicted by COMPASS (Ma et al. 1998), which has been
shown to accurately predict chromosomal location and
gene identification via comparative mapping of cattle and
humans (Rebeiz & Lewin 2000).
Radiation hybrid panel
Gene specific PCR primers (Table 1) were screened across a
bovine radiation hybrid panel (Womack et al. 1997) and a
bovine somatic cell hybrid panel (Womack & Moll 1986) to
determine chromosomal location. Statistical analysis of
chromosomal location of the genes was completed in col-
laboration with Dr James Womack and Dr Srivinas Kata,
Texas A & M University. Genes that could not be
unambiguously assigned to a single chromosomal location
using the radiation hybrid panel were mapped on the
somatic cell hybrid panel.
Results
Embryo collection
This experiment utilized Piedmontese cross animals, which
carried one copy of an A to G transition mutation that
inactivates myostatin (Kambadur et al. 1997). Fifty-two
embryos (average 3.2 per pregnant cow) ranging from 30 to
32 days post-insemination were collected. This strategy was
predicted to minimize background genetic variation and its
impact on gene expression measurements, as embryos from
all genotypic classes (0, 1 or 2 double-muscled alleles)
would be generated from a limited genetic background.
However, genotyping of the 52 embryos revealed the pres-
ence of 18 homozygous normal, 34 heterozygous, and
0 homozygous double-muscle embryos (deviation from a
1 : 2 : 1 ratio, v2 ¼ 17.4). It should be noted that no
abnormal or reabsorbing embryos were encountered during
dissection of the reproductive tracts.
It is assumed that the failure to obtain the predicted
1 : 2 : 1 ratio of genotypes was related in some way to the
superovulation procedure. To avoid this complication, the
experiment was repeated by artificial insemination of syn-
chronized cows that were not superovulated. Additional
Piedmontese animals were not available, so Belgian Blue
cross animals, which carried one copy of an 11 bp deletion
that inactivates myostatin (Kambadur et al. 1997) were
used. Twenty-three embryos were produced, with five
homozygous normal, 14 heterozygous, and four homozy-
gous double-muscled embryos. These embryos did not
deviate from the expected 1 : 2 : 1 ratio (v2 ¼ 1.036).
Table 1 Primer information for genes mapped
with radiation hybrid and somatic cell hybrid
panel.
Gene Primer sequences Annealing
ATP5H 5¢-CCTCACGGAGCCTACCATCA-3¢ 5¢-CACGGGCCCTGACTACANTT-3¢ 59
MLL2 5¢-GTACAGAAGGCAAGCGACAG-3¢ 5¢-CAGAGAGGTACATGCTGCAG-3¢ 61
HMGA2 5¢-ACTTGCAAAGACCTACCTCCA-3¢ 5¢-AACCATCTCTCTTCCAGCCG-3¢ 64
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Differential expression
BLAST analysis of sequence data obtained from 58 unique
cDNA clones isolated using suppressive subtractive hybrid-
ization indicated that there were 30 differentially expressed
genes. Eleven genes were isolated from wild-type cDNA that
had been subtracted with double-muscle cDNA, suggesting
that expression for these genes was at a greater level in the
wild type embryos than in the double-muscled embryos.
Nineteen genes were identified from double-muscled cDNA
that had been subtracted with wild-type cDNA, suggesting
that they were expressed at a higher level in the double-
muscled embryos.
To verify the results of the subtractive hybridization,
macroarray analysis of gene expression was performed with
the 30 cDNA identified by SSH. These arrays were probed
with radiolabelled cDNA from either wild-type or double-
muscled embryos. Nineteen genes were found to have at
least a twofold difference in expression levels of wild-type
and double-muscled embryos (Table 2). The remaining
Table 2 Genes identified by suppression
subtraction hybridization.
EST name Symbol1
Homology
to human
(%)
Myostatin
response2
Chromosomal
location
GenBank
accession
number
DMA1 DDX17 82 0.67 54 CF195394
DME6 SALL1 89 2.50* 183 CB603720
DME7 SET 95 1.01 8,114 CB603721
DMD11 RAB2 90 1.36 146 CB603719
DMA2 KIAA0697 85 22.80* 64 CB603713
DMA4 ACTB 90 1.87 34 CF195395
DMA5 RPL18 83 14.17* 77 CB603714
DMA12 TF 98 0.64 18 CB603712
DMB9 Unique – 2.43* – CB603717
DMB11 SOD1 90 2.03* 39 CB603716
DMD1 HBE1 88 3.52* 15,254 CB603718
DMA7 MTND5 87 1.64 13,184 CB603715
DMG1 TMSB10 98 2.44* 24 CB603722
WTB5 MLL2 94 0.16* 53 CB603729
WTC2 ATP5H 95 0.24* 53,5 CB603732
WTH3 HMGA2 90 0.24* 53 CB603739
WTE5 RAF1 91 0.19* 228 CB603735
WTH10 RPL3 99 0.29* 510 CB603738
WTB8 EEF1A1 98 1.03 64 CB603731
WTF4 RPS5 87 0.52 94 CB603736
WTA3 AFP 86 0.91 6,174 CB603724
WTA4 Unique – 0.24* – CB603725
WTA5 RPL11 90 0.23* 15,14 CB603726
WTA6 TUBB 93 0.19* 184 CB603727
WTA9 RPS9 94 1.46 7,184 CB603728
WTA10 HBZ 98 0.26* 29,54 CB603723
WTB6 TUBGCP6 89 0.21* 22,174 CB603730
WTD4 Unique – 0.41* – CB603733
WTF8 PTMA 90 1.10 74 CB603737
WTE11 RPS3 85 0.35* 67 CB603734
1Gene name was determined by the closet human homologue. Identity had to be greater than
80% over a distance of >60 bp.
2Response is reported as wild-type expression divided by double-muscled. Those genes with a
greater than twofold difference in expression are denoted with an asterisk.
3Assigned to chromosomal location using a bovine radiation hybrid panel (Womack et al. 1997).
4Assigned to chromosomal location using COMPASS (Ma et al. 1998).
5Assigned to chromosomal location using a bovine somatic cell hybrid panel (Womack & Moll
1986).
6Band et al. (2000).
7Wang et al. (2001).
8Threadgill et al. (1991).
9Heuertz & Hors-Cayla (1981).
10Allan et al. (2001).
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11 clones were not differentially expressed (less than two-
fold change). The mRNA expression level for 12 clones was
greater in double-muscled vs. wild-type embryos, whereas
the mRNA expression level of seven clones was greater in
wild-type vs. double-muscled embryos.
Chromosomal location
Gene identification and chromosomal location (Table 2)
were predicted for 27 clones using COMPASS (Ma et al.
1998). Comparative mapping suggested that HMGA2,
MLL2, and ATP5H mapped on bovine chromosome 5
(BTA5), which also contains a myostatin interacting QTL
for day 14 Warner–Bratzler shear force (Casas et al. 2000).
Therefore, to more precisely map these loci, a radiation
hybrid panel was screened with primers developed for these
three genes (Table 1). HMGA2 was located centromeric to
glucosamine (N-acetyl)-6-sulphatase (GNS) and MLL2 was
positioned telomeric to alpha-lactalbumin B (LALBA;
Fig. 1). Although ATP5H could not be assigned to a single
chromosomal location using the radiation hybrid panel, it
was positioned on BTA5 using a bovine somatic cell hybrid
panel (Womack & Moll 1986) with 94% confidence.
Discussion
Failure to obtain double-muscled bovine embryos from
super ovulated cows has two possible explanations. First,
follicles carrying the double-muscled mutation may not
have ovulated using a super-ovulation regime. This possi-
bility is eliminated in that heterozygous embryos were
obtained in the experiment. Alternatively, it is possible that
homozygous double-muscled embryos, which lacked func-
tional myostatin alleles and were obtained from super
ovulated cows, died shortly after transfer. The reason for
this death is not obvious.
The present study was designed to use the SSH method
for identification and mapping of functional candidate genes
for myostatin interacting alleles. In particular, we were
interested in genes differentially expressed shortly after the
first expression of myostatin in the developing bovine
embryo. Comparisons of double-muscled and normal-mus-
cled animals have revealed differences in gene expression,
protein synthesis, energy homeostasis, and myofibre and
adipose number (Hanset 1986; Oldham et al. 2001). Genes
identified in this study appear to fall into general gene
classes including transcription factors (n ¼ 5), genes
involved in protein synthesis and degradation (n ¼ 8), cell
proliferation (n ¼ 3), or altered metabolism (n ¼ 4).
The mRNA expression level of Sall1 and high mobility
group AT-hook 2 (HMGA2), which are both transcription
factors, was decreased in embryos that were homozygous
for the double-muscled mutation. Sall1 is a spalt-like gene,
which in Drosophila is a downstream target of decapenta-
palegic, a TGFB superfamily member (de Celis et al. 1996;
Nellen et al. 1996). HMGA2 is involved in fat cell prolifer-
ation, as HMGA2 knockout mice have a decrease number
of adipose cells (Anand & Chada 2000). In addition,
inactivation of HMGA2 in mice results in a pygmy pheno-
type, which indicates that HMGA2 is required for normal
cell proliferation (Zhou et al. 1995). Thus, decreased
HMGA2 expression could be a possible mechanism whereby
myoblast and adipose proliferation is decreased in embryos
with non-functional myostatin alleles.
RPL18, RPL3, RPL11, and RPS3 are all involved in
protein synthesis and degradation. Ribosomal protein L18
has been shown to inhibit double-stranded RNA protein
kinase (PKR), which plays an important role in the regu-
lation and inhibition of protein synthesis (Koromilas et al.
1992; Kumar et al. 1999). Also, ribosomal protein L3
expression is increased in mouse lines with higher fat
deposition (Allan et al. 2001). The differential expression of
these genes indicates that there may be differences in pro-
tein synthesis and degradation between wild-type and
double-muscled embryos.
RAF1, thymosin beta-10 (TMSB10), and myeloid-lineage
leukaemia (MLL2) are involved in regulation of cell prolif-
eration. In C2C12 cells, RAF1 has been shown to enhance
the transcriptional activity of MYOD1 (Gredinger et al.
1998). The decreased level of RAF1 expression observed in
wild-type animals may decrease MYOD1 functional activity,
thus indicating a mechanism in addition to decreased
MYOD1 expression (Langley et al. 2002) whereby myosta-
tin represses terminal differentiation. As myostatin is known
to inhibit cell proliferation (Thomas et al. 2000), these genes
may have an important role in the increased myoblast
proliferation associated with this phenotype.
It has been reported that several chromosomes harbour
suggestive QTL that contain alleles that interact with
Figure 1 Physical and linkage map of ATP5H, MLL2, HMGA2, and
associated markers. BTA5 represents the cytogenetic map of bovine
chromosome 5. On the right hand side, radiation hybrid panel mapping
results are shown, along with markers that were near each gene (Band
et al. 2000).
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myostatin. A suggestive interaction between alternative
myostatin alleles and the genetic background on chromo-
some 5 was identified for Warner Bratzler shear force (WBS)
at day 14 post-mortem (WBS14; Casas et al. 2000). Similar
interactions with myostatin appear to exist on chromosome
8 and 14 for fat depth (Casas et al. 2000) and chromosome
4 for WBS at 3 days post-mortem (Casas et al. 2000, 2001).
MLL2, HMGA2 and ATP5JD, identified in this study, were
physically mapped to bovine chromosome 5 very close to
the WBS14-interacting QTL peak.
Despite the fact that SSH was successfully used to identify
differentially expressed genes, one must be aware of poten-
tial limitation of suppressive subtractive hybridization ana-
lysis. First, 11 genes appeared to have escaped subtraction
as they had lower than twofold change in gene expression.
Thus, differential expression of all identified genes must be
verified with an alternative method. Furthermore, embryos
used in this study were obtained from crossbred cattle. The
possibility exists that differences in genetic background were
responsible for the observed changes in gene expression. For
example, there are changes in fatty acid binding protein
gene expression in pigs, which correlate with different
genotypes (Gerbens et al. 2001).
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